Dabrafenib Mesylate and Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
Determining the interaction of Dabrafenib Mesylate and Emtricitabine, Rilpivirine, and Tenofovir Alafenamide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: emtricitabine / rilpivirine / tenofovir alafenamide
Brand name: Odefsey, Complera
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Dabrafenib Mesylate-Emtriva
- Dabrafenib Mesylate-Emtriva (Emtricitabine Capsules)
- Dabrafenib Mesylate-Emtriva (Emtricitabine Solution)
- Dabrafenib Mesylate-Emverm
- Dabrafenib Mesylate-Enablex
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Dacarbazine
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Dacarbazine Intravenous, Injection
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Daclatasvir
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Daclatasvir Dihydrochloride
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Daclizumab
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Daclizumab Subcutaneous